Increased life expectancy and changes in age structure will drive the number of global prostate cases from 1.4 million to 2.9 million by 2040, according to a new report published in The Lancet.

The report, published by the Lancet Commission on prostate cancer, also predicts an 85 percent increase in prostate cancer mortality from 375,000 in 2020 to almost 700,000 in 2040, primarily in men living in lower- and middle-income countries where late-stage prostate cancer diagnosis continues to be common.